We will continue to take action to stop these illegal actors and urgently call on regulators and law enforcement to do the same. In February, several compounding pharmacies sued the FDA for removing Mounjaro, Zepbound and other similar name-brand medications from the shortage list, according to Reuters
Tomatoes: And who doesn't love tomatoes
Vacca M, Kamzolas I, Harder LM et al (2024) An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
The winners will be the assets that close it: either via oral formulations that improve adherence (ASC37, SP-2297, Rani), via long-interval dosing that reduces attrition (monthly ASC37 SC, Fc-fusion MWN-101/ZX2021), via better tolerability ratios (small-molecule HM-15275), or via combination formulations that add amylin or calcitonin effects on top of the triple agonist (AstraZeneca's combination-centric patent position is the early signal of this thesis)
Natural Sciences, Cum Laude Certification American Board of Allergy and Immunology Passed 10/10 American Board of Pediatrics Passed 10/08 USMLE STEP 1 Passed 7/03 USMLE STEP 2 Passed 10/04 USMLE STEP 3 Passed 4/07 PALS received 9/07 Professional Memberships American Academy of Allergy, Asthma & Immunology 7/08- present American College of Allergy, Asthma & Immunology 7/08- present Louisiana Society of Allergy, Asthma & Immunology 6/08- 6/10 American Association of Pediatrics 10/04- present Abstracts/Publications/Appearances Appearance on NBC4 Fall 2016, Spring 2017 Allergists view new pills as limited article in The Columbus Dispatch Feb 14, 2014 Appearance on Daytime Columbus March 19 (Spring Allergies) and March 26 th (Allergy Medications) 2013 Appearance on Good Day Columbus April 9 2013 (Spring Allergies) Appearance on Good Day September 14, 2013 (Fall Allergies) Gital Karamchandani-Patel, Eric P
